Shanghai (1)

Efficacy, Self (1)

Refractory Leukemia (1)

Refractory Lymphoma (1)

Relapsed Disease (1)

Safety (1)

T-lymphoblastic Lymphoma (1)

Recruiting (1)

phase 2 (1)

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (1)

bcl2 inhibitor plus im2 regimen (1)

drug (1)

Other (1)

Interventional (1)

relapsed disease

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recruiting

Shanghai, Shanghai, China

Shanghai General hospital,Shanghai Jiao Tong University School o

Jan 10, 2023